Research publications

Alfred Health research outcomes are published in a wide range of peer reviewed journals. 

Search or browse research publications by year, research area, publication type or keyword.

Clear filter
Publication Details
Disseminated enteroviral infection associated with obinutuzumab

Dendle C, Gilbertson M, Korman TM, Golder V, Morand E, Opat S

(2015), Emerg Infect Dis, 21(9), 1661-3

Immunohistological description of nongestational ovarian choriocarcinoma in two female mice with conditional loss of Trp53 driven by the Tie2 promoter

Castiglioni V, Farhang Ghahremani M, Goossens S, De Maglie M, Ardizzone M, Haigh JJ, Radaelli E

(2015), Vet Pathol, 52(4), 752-6

Thrombin-induced reactive oxygen species generation in platelets: a novel role for protease-activated receptor 4 and GPIbα

Carrim N, Arthur JF, Hamilton JR, Gardiner EE, Andrews RK, Moran N, Berndt MC, Metharom P

(2015), Redox Biol, 6, 640-7

Comparison of intermittent and continuous extracorporeal treatments for the enhanced elimination of dabigatran

Bouchard J, Ghannoum M, Bernier-Jean A, Williamson D, Kershaw G, Weatherburn C, Eris JM, Tran H, Patel JP, Roberts DM

(2015), Clin Toxicol, 53(3), 156-63

Dendritic cell-mediated phagocytosis but not immune activation is enhanced by plasmin

Borg RJ, Samson AL, Au AE, Scholzen A, Fuchsberger M, Kong YY, Freeman R, Mifsud NA, Plebanski M, Medcalf RL

(2015), PLoS One, 10(7), e0131216

Strategies to rescue the consequences of inducible arginase-1 deficiency in mice

Ballantyne LL, Sin YY, St Amand T, Si J, Goossens S, Haenebalcke L, Haigh JJ, Kyriakopoulou L, Schulze A, Funk CD

(2015), PLoS One, 10(5), e0125967

MDX-1097 induces antibody-dependent cellular cytotoxicity against kappa multiple myeloma cells and its activity is augmented by lenalidomide

Asvadi P, Cuddihy A, Dunn RD, Jiang V, Wong MX, Jones DR, Khong T, Spencer A

(2015), Br J Haematol, 169(3), 333-43

ADAMs control inflammation from afar

Andrews RK, Gardiner EE

(2015), J Leukoc Biol, 97(3), 437-8

Modifying chemotherapeutic management of a patient with Burkitt’s lymphoma and pre-existing motor neurone disease

Bortz H, Coutsouvelis J, Corallo CE, Spencer A, Patil S

(2015), J Clin Pharm Ther, 40(4), 483-5

Efficacy of an Fc-modified anti-CD123 antibody (CSL362) combined with chemotherapy in xenograft models of acute myelogenous leukemia in immunodeficient mice

Lee EM, Yee D, Busfield SJ, McManus JF, Cummings N, Vairo G, Wei A, Ramshaw HS, Powell JA, Lopez AF, Lewis ID, McCall MN, Lock RB

(2015), Haematologica, 100(7), 914-26

Immunological markers for prognostication in cytogenetically normal acute myeloid leukemia

Ling VY, Lee D, McQuilten Z, Avery S, Low M, Cody SH, Nguyen T, McLean C, Gorniak M, Wei A, Ting SB

(2015), Am J Hematol, 90(12), E219-20

Treating pulmonary embolism in Pacific Asia with direct oral anticoagulants

Cohen A, Jeyaindran S, Kim JY, Park K, Sompradeekul S, Tambunan KL, Tran H, Tsai IC, Ward C, Wong R

(2015), Thromb Res, 136(2), 196-207

Maintenance lenalidomide in combination with 5-azacitidine as post-remission therapy for acute myeloid leukaemia

Wei A, Tan P, Perruzza S, Govindaraj C, Fleming S, McManus J, Avery S, Patil S, Stevenson W, Plebanski M, Spencer A

(2015), Br J Haematol, 169(2), 199-210

Low levels of CD9 coincidental with a novel nonsense mutation in glycoprotein Ibβ in a patient with Bernard-Soulier syndrome

Qiao J, Davis AK, Morel-Kopp MC, Ward CM, Gardiner EE, Andrews RK

(2015), Ann Hematol, 94(12), 2069-71

Traumatic brain injury opens blood-brain barrier to stealth liposomes via an enhanced permeability and retention (EPR)-like effect

Boyd BJ, Galle A, Daglas M, Rosenfeld JV, Medcalf R

(2015), J Drug Target, 23(9), 847-53

Extracorporeal membrane oxygenation-hemostatic complications

Murphy DA, Hockings LE, Andrews RK, Aubron C, Gardiner EE, Pellegrino VA, Davis AK

(2015), Transfus Med Rev, 29(2), 90-101

Activation of the erythroid K-Cl cotransporter Kcc1 enhances sickle cell disease pathology in a humanized mouse model

Brown FC, Conway AJ, Cerruti L, Collinge JE, McLean C, Wiley JS, Kile BT, Jane SM, Curtis DJ

(2015), Blood, 126(26), 2863-70

Inositol polyphosphate 4-phosphatase II (INPP4B) is associated with chemoresistance and poor outcome in AML

Rijal S, Fleming S, Cummings N, Rynkiewicz NK, Ooms LM, Nguyen NY, Teh TC, Avery S, McManus JF, Papenfuss AT, McLean C, Guthridge MA, Mitchell CA, Wei AH

(2015), Blood, 125(18), 2815-24

Approval of the first protease-activated receptor antagonist: rationale, development, significance, and considerations of a novel anti-platelet agent

French SL, Arthur JF, Tran HA, Hamilton JR

(2015), Blood Rev, 29(3), 179-89

R-CHOP with or without bevacizumab in patients with previously untreated diffuse large B-cell lymphoma: final MAIN study outcomes

Seymour JF, Pfreundschuh M, Trnĕný M, Sehn LH, Catalano J, Csinady E, Moore N, Coiffier B; MAIN Study Investigators

(2014), Haematologica, 99(8), 1343-9

25 26 27 28 29